HealthTree Logo
search more_vert
close
person Sign In / Create Account

Clinical Expertise

Chronic lymphocytic leukemia (CLL)

About

About Dr. Keating

Over the last 30 years, he has been involved in clinical research in chronic lymphocytic leukemia (CLL). During this time the complete remission rate has risen dramatically from approximately 5% to 50 – 60%. This is associated with improvements in developmental therapeutic programs but also a dramatic improvement in the understanding of the biology and prognostic factors of CLL. CLL is a disease of the elderly and the characterization of other cancers in survivors of CLL is vitally important. Understanding of this comparison between incidence and characteristics of other cancers in CLL survivors is vitally important in its own right but must be integrated into clinical understanding of the disease. He is totally committed to providing clinical and intellectual resources at his disposal to support the program.

Location

MD Anderson Cancer Center: 1515 Holcombe Blvd, Houston, TX 77030, USA

Get the latest thought leadership on Chronic Lymphocytic Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Chronic Lymphocytic Leukemia Newsletter" for Chronic Lymphocytic Leukemia news, life with Chronic Lymphocytic Leukemia stories, Chronic Lymphocytic Leukemia clinical trials, Chronic Lymphocytic Leukemia 101 articles and events with Chronic Lymphocytic Leukemia experts.

Thanks to our HealthTree Community for Chronic Lymphocytic Leukemia Sponsors:

Abbvie
Genentech

Follow Us

facebook instagram youtube